BBS shows strong inhibitory activity in the middle and late stages of the EV71 activity cycle and could dramatically block the multiplication of the virus and activate the immune response of cells against viral infection, thus reducing the extent of EV71-induced pathologies in the lungs, brain, and skeletal muscle tissues. This evidence concerns the gene BBS2 and viral infectious disease.